Can FMC Technologies (FTI) Run Higher on Rising Earnings Estimates?

09.03.26 17:20 Uhr

Werte in diesem Artikel
Aktien

14,43 EUR -0,56 EUR -3,70%

38,70 EUR 0,10 EUR 0,26%

1.400,00 JPY 0,00 JPY 0,00%

61,33 EUR 1,35 EUR 2,25%

Indizes

PKT PKT

1.978,4 PKT -10,8 PKT -0,54%

2.039,6 PKT -11,5 PKT -0,56%

23.168,1 PKT -130,8 PKT -0,56%

8.634,5 PKT -67,5 PKT -0,78%

1.814,0 PKT -25,7 PKT -1,40%

2.975,3 PKT 0,8 PKT 0,03%

2.143,9 PKT 0,6 PKT 0,03%

219,4 PKT 0,3 PKT 0,14%

609,5 PKT -2,7 PKT -0,44%

12.265,4 PKT -73,6 PKT -0,60%

23.213,0 PKT -95,0 PKT -0,41%

23.146,7 PKT -107,5 PKT -0,46%

8.944,7 PKT -54,0 PKT -0,60%

16.328,5 PKT 0,0 PKT 0,00%

1.854,4 PKT -8,4 PKT -0,45%

FMC Technologies (FTI) appears an attractive pick given a noticeable improvement in the company's earnings outlook. The stock has been a strong performer lately, and the momentum might continue with analysts still raising their earnings estimates for the company.Analysts' growing optimism on the earnings prospects of this provider of equipment and services to energy companies is driving estimates higher, which should get reflected in its stock price. After all, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. This insight is at the core of our stock rating tool -- the Zacks Rank.The five-grade Zacks Rank system, which ranges from a Zacks Rank #1 (Strong Buy) to a Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record of outperformance, with Zacks #1 Ranked stocks generating an average annual return of +25% since 2008.For FMC Technologies, there has been strong agreement among the covering analysts in raising earnings estimates, which has helped push consensus estimates considerably higher for the next quarter and full year.The chart below shows the evolution of forward 12-month Zacks Consensus EPS estimate:12 Month EPSCurrent-Quarter Estimate RevisionsFor the current quarter, the company is expected to earn $0.56 per share, which is a change of +69.7% from the year-ago reported number.Over the last 30 days, eight estimates have moved higher for FMC Technologies while one has gone lower. As a result, the Zacks Consensus Estimate has increased 5.62%.Current-Year Estimate RevisionsFor the full year, the company is expected to earn $2.89 per share, representing a year-over-year change of +18.0%.In terms of estimate revisions, the trend for the current year also appears quite encouraging for FMC Technologies. Over the past month, 10 estimates have moved higher compared to no negative revisions, helping the consensus estimate increase 5.36%.Favorable Zacks RankThe promising estimate revisions have helped FMC Technologies earn a Zacks Rank #1 (Strong Buy). The Zacks Rank is a tried-and-tested rating tool that helps investors effectively harness the power of earnings estimate revisions and make the right investment decision.You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.Our research shows that stocks with Zacks Rank #1 (Strong Buy) and 2 (Buy) significantly outperform the S&P 500.Bottom LineInvestors have been betting on FMC Technologies because of its solid estimate revisions, as evident from the stock's 6.7% gain over the past four weeks. As its earnings growth prospects might push the stock higher, you may consider adding it to your portfolio right away.5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in the coming year. While not all picks can be winners, previous recommendations have soared +112%, +171%, +209% and +232%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report TechnipFMC plc (FTI): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: FMC und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Quelle: Zacks

Nachrichten zu Fresenius Medical Care (FMC) St.

Analysen zu Fresenius Medical Care (FMC) St.

DatumRatingAnalyst
13.03.2026Fresenius Medical Care (FMC) St UnderweightJP Morgan Chase & Co.
13.03.2026Fresenius Medical Care (FMC) St KaufenDZ BANK
12.03.2026Fresenius Medical Care (FMC) St Equal WeightBarclays Capital
10.03.2026Fresenius Medical Care (FMC) St SellUBS AG
02.03.2026Fresenius Medical Care (FMC) St HoldDeutsche Bank AG
DatumRatingAnalyst
13.03.2026Fresenius Medical Care (FMC) St KaufenDZ BANK
03.12.2025Fresenius Medical Care (FMC) St BuyJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
07.11.2025Fresenius Medical Care (FMC) St BuyGoldman Sachs Group Inc.
05.11.2025Fresenius Medical Care (FMC) St KaufenDZ BANK
15.08.2025Fresenius Medical Care (FMC) St KaufenDZ BANK
DatumRatingAnalyst
12.03.2026Fresenius Medical Care (FMC) St Equal WeightBarclays Capital
02.03.2026Fresenius Medical Care (FMC) St HoldDeutsche Bank AG
27.02.2026Fresenius Medical Care (FMC) St Equal WeightBarclays Capital
25.02.2026Fresenius Medical Care (FMC) St HoldDeutsche Bank AG
24.02.2026Fresenius Medical Care (FMC) St Equal WeightBarclays Capital
DatumRatingAnalyst
13.03.2026Fresenius Medical Care (FMC) St UnderweightJP Morgan Chase & Co.
10.03.2026Fresenius Medical Care (FMC) St SellUBS AG
02.03.2026Fresenius Medical Care (FMC) St UnderperformJefferies & Company Inc.
25.02.2026Fresenius Medical Care (FMC) St UnderweightJP Morgan Chase & Co.
24.02.2026Fresenius Medical Care (FMC) St SellUBS AG

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Fresenius Medical Care (FMC) St. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen